In this context, we investigated whether CTGF reduction in podocytes could ameliorate anti-GBM nephritis using pod-CTGF cKO mice, because CTGF has been shown to be upregulated by podocytes and mesangial cells in crescentic glomerulonephritis in both humans and rats13, 28. Here, CCN2 is linked to nephritis.